Is Prelude Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 08:01 PM IST
share
Share Via
As of September 8, 2025, Prelude Therapeutics, Inc. shows a mildly bullish trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and underperformance compared to the S&P 500.
As of 8 September 2025, the technical trend for Prelude Therapeutics, Inc. has changed from sideways to mildly bullish. The weekly MACD and KST indicators are both mildly bullish, while the monthly MACD is also mildly bullish, supporting a positive outlook. The daily moving averages are bullish, further reinforcing this stance. However, the monthly Bollinger Bands and KST are bearish, indicating some caution. The RSI shows a bullish signal on a monthly basis but no signal on the weekly. Overall, the indicators suggest a mildly bullish stance, albeit with some mixed signals.

In terms of performance, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a YTD return of -20.78% versus the S&P 500's 12.22%, and a 1Y return of -58.61% compared to 17.14% for the index.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News